Flavonoid · Fact sheet
Quercetin
Quercetin is a plant flavonoid with small human studies of blood pressure and biomarkers. Results are mixed, and studies combining it with dasatinib cannot establish the effects of quercetin alone.
What is Quercetin?
Quercetin is present in many plant foods and is also studied as a concentrated supplement. It is distinct from the experimental dasatinib–quercetin drug combination.
Benefits & claims
Inflammation, immune support, allergies, cardiovascular health, and senescent-cell clearance attract interest. These are separate claims with different evidence requirements.
What the evidence supports
- One 93-person study found a modest reduction in systolic blood pressure.
- Mixed overall and subgroup findings do not establish prevention of cardiovascular events or a longevity benefit.
Research areas
- Blood pressure
- Oxidative-stress markers
- Senescence-related research
Dosage & frequency
Human study contextQuercetin supplement studies do not establish a senolytic or longevity prescription. Quercetin alone is different from the experimental dasatinib–quercetin combination.
Randomized cardiovascular-risk crossover study
Overweight adults with a high-cardiovascular-risk phenotype
- Amount
- 150 mg/day
- Frequency
- Daily during six-week study periods
- Route studied or labeled
- Oral
Blood-pressure and biomarker research; not a senolytic prescription.
How to read these amounts
An approved regimen belongs to a specific product, indication, and population. A study regimen describes what researchers tested; it does not establish a prescription or a safe self-use protocol. Products, routes, and formulations are not interchangeable. A prescriber uses the full label and individual clinical circumstances.
Personal accounts may describe amounts, schedules and outcomes beyond clinical research. They do not establish a regimen. Read the reported experiences
Formulations, interactions & practical context
Formulation differences
- Food intake, supplement formulations, and combination trials represent different exposures.
Interactions & precautions
- A cardiovascular-risk supplement trial does not establish high-dose interaction safety, particularly for the separate dasatinib–quercetin combination.
What is still unresolved
- A clinically effective regimen, long-term benefit, and interaction profile at high exposure remain uncertain.
Side effects & risks
- Short studies in selected participants do not establish long-term safety or uncommon side-effect rates.
- Findings from a combination with a prescription cancer medicine cannot be used as a safety assessment of either ingredient alone.
This is a summary of the cited evidence, not a complete product label. A lack of human safety data does not establish safety.
Clinical research
Early human evidenceShort crossover studies report small blood-pressure changes in selected groups. A 70-person trial found no overall effect on 24-hour blood pressure, although a hypertension subgroup improved.
Studies
93 participants; small systolic blood-pressure changes over six-week periods.
No overall 24-hour blood-pressure effect; a hypertensive subgroup differed.
Personal experiences
Reports describe what someone noticed. They cannot establish cause, typical results, or how often a side effect happens. Amounts and schedules describe the individual account, not an effective or safe dose. Product identity and strength may be unverified, and missing details are left explicit.
Explore 3 sourced accounts by reported effect.
Energy: reported experiences
Clearer thinking, with ongoing sleep problems
An author described less brain fog, fatigue and distress after adding quercetin with bromelain. Insomnia and itchy eyes and throat persisted.
Reported use in this account
- Product
- Quercetin with bromelain capsules
- Amount
- 800 mg in two capsules, as reported
- Frequency
- Daily, in the morning
- Route
- Oral capsules
- Duration
- Three weeks at the time of the post
Other exposures described: Bromelain; Pepcid (famotidine); Zyrtec (cetirizine); NAC; Other vitamins
The author had no confirmed MCAS diagnosis and also used antihistamines, NAC and vitamins. Improvement cannot be assigned to quercetin alone.
Read the original accountSleep: reported experiences
Clearer thinking, with ongoing sleep problems
An author described less brain fog, fatigue and distress after adding quercetin with bromelain. Insomnia and itchy eyes and throat persisted.
Reported use in this account
- Product
- Quercetin with bromelain capsules
- Amount
- 800 mg in two capsules, as reported
- Frequency
- Daily, in the morning
- Route
- Oral capsules
- Duration
- Three weeks at the time of the post
Other exposures described: Bromelain; Pepcid (famotidine); Zyrtec (cetirizine); NAC; Other vitamins
The author had no confirmed MCAS diagnosis and also used antihistamines, NAC and vitamins. Improvement cannot be assigned to quercetin alone.
Read the original accountMood: reported experiences
Anxiety and racing thoughts
An author reported anxiety and racing thoughts during several weeks of quercetin with L-glutamine. Symptoms had improved, but not fully resolved, nearly a month after stopping.
Reported use in this account
- Product
- Quercetin supplement
- Amount
- 1,800 mg per day, as reported
- Frequency
- Daily
- Route
- Not specified clearly
- Duration
- About three weeks
Other exposures described: L-glutamine
Two supplements changed together. The account cannot identify the cause or verify the author's proposed explanation.
Read the original accountClearer thinking, with ongoing sleep problems
An author described less brain fog, fatigue and distress after adding quercetin with bromelain. Insomnia and itchy eyes and throat persisted.
Reported use in this account
- Product
- Quercetin with bromelain capsules
- Amount
- 800 mg in two capsules, as reported
- Frequency
- Daily, in the morning
- Route
- Oral capsules
- Duration
- Three weeks at the time of the post
Other exposures described: Bromelain; Pepcid (famotidine); Zyrtec (cetirizine); NAC; Other vitamins
The author had no confirmed MCAS diagnosis and also used antihistamines, NAC and vitamins. Improvement cannot be assigned to quercetin alone.
Read the original accountFocus: reported experiences
Clearer thinking, with ongoing sleep problems
An author described less brain fog, fatigue and distress after adding quercetin with bromelain. Insomnia and itchy eyes and throat persisted.
Reported use in this account
- Product
- Quercetin with bromelain capsules
- Amount
- 800 mg in two capsules, as reported
- Frequency
- Daily, in the morning
- Route
- Oral capsules
- Duration
- Three weeks at the time of the post
Other exposures described: Bromelain; Pepcid (famotidine); Zyrtec (cetirizine); NAC; Other vitamins
The author had no confirmed MCAS diagnosis and also used antihistamines, NAC and vitamins. Improvement cannot be assigned to quercetin alone.
Read the original accountSkin: reported experiences
Less congestion after an uncomfortable reaction
An author described easier nasal breathing after two days of quercetin with bromelain, preceded by flushing, tingling, head pain and sore, swollen lymph nodes.
Reported use in this account
- Product
- Quercetin with bromelain tablets
- Amount
- Not specified clearly
- Frequency
- Twice daily
- Route
- Oral tablets
- Duration
- Two days
Other exposures described: Bromelain
This is a short combination-product account. The author's proposed mechanism is unverified, and a requested longer follow-up was not available.
Read the original accountHeadache: reported experiences
Less congestion after an uncomfortable reaction
An author described easier nasal breathing after two days of quercetin with bromelain, preceded by flushing, tingling, head pain and sore, swollen lymph nodes.
Reported use in this account
- Product
- Quercetin with bromelain tablets
- Amount
- Not specified clearly
- Frequency
- Twice daily
- Route
- Oral tablets
- Duration
- Two days
Other exposures described: Bromelain
This is a short combination-product account. The author's proposed mechanism is unverified, and a requested longer follow-up was not available.
Read the original accountSensory changes: reported experiences
Less congestion after an uncomfortable reaction
An author described easier nasal breathing after two days of quercetin with bromelain, preceded by flushing, tingling, head pain and sore, swollen lymph nodes.
Reported use in this account
- Product
- Quercetin with bromelain tablets
- Amount
- Not specified clearly
- Frequency
- Twice daily
- Route
- Oral tablets
- Duration
- Two days
Other exposures described: Bromelain
This is a short combination-product account. The author's proposed mechanism is unverified, and a requested longer follow-up was not available.
Read the original accountBreathing: reported experiences
Less congestion after an uncomfortable reaction
An author described easier nasal breathing after two days of quercetin with bromelain, preceded by flushing, tingling, head pain and sore, swollen lymph nodes.
Reported use in this account
- Product
- Quercetin with bromelain tablets
- Amount
- Not specified clearly
- Frequency
- Twice daily
- Route
- Oral tablets
- Duration
- Two days
Other exposures described: Bromelain
This is a short combination-product account. The author's proposed mechanism is unverified, and a requested longer follow-up was not available.
Read the original accountApproval status
Quercetin has no FDA-approved drug indication for the wellness uses discussed here. Supplement availability is not premarket FDA approval of effectiveness or safety.
Supplement research is not FDA drug approval
Approval covers the labeled product, use and population. A trial phase does not establish success; a stopped program is not ongoing research.
Open questions
- Clinical outcomes beyond small biomarker changes
- Long-term supplement safety and interactions
- Effects of quercetin alone on senescent cells in humans
Summary
Mixed overall and subgroup findings do not establish prevention of cardiovascular events or a longevity benefit.
Sources
Medical evidence and regulatory sources are listed here. Personal reports are linked separately in the experiences section.
- pubmedQuercetin crossover study in adults with metabolic risk
93 participants; small systolic blood-pressure changes over six-week periods.
- pubmedQuercetin and ambulatory blood pressure
No overall 24-hour blood-pressure effect; a hypertensive subgroup differed.
- fdaFDA: what approval means for supplements
Dietary supplements are not approved by FDA for safety and effectiveness before marketing.